Litcius/Paper detail

Estradiol exerts a neuroprotective effect on SH‐SY5Y cells through the miR‐106b‐5p/TXNIP axis

Qiong Pan, Ke Guo, Min Xue, Qiuyun Tu

2021Journal of Biochemical and Molecular Toxicology15 citationsDOI

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease. Thioredoxin and thioredoxin-interacting protein (TXNIP) complexes help sustain cell oxidation/reduction balance. In the present study, we verified the neuroprotective role of estradiol against amyloid-beta 42 in SH-SY5Y cells through inhibiting TXNIP expression, promoting cell viability and DNA synthesis ability, inhibiting cell apoptosis, and affecting caspase and Bax/Bcl-2 apoptotic signaling. miR-106b-5p could bind to TXNIP 3'-untranslated region to inhibit the expression level of TXNIP. Within SH-SY5Y cells, miR-106b-5p inhibition repressed cell viability and DNA synthesis ability and promoted cell apoptosis through caspase and Bax/Bcl-2 apoptotic signaling, while miR-106b-5p overexpression or TXNIP knockdown exerted the opposite effects on SH-SY5Y cells; TXNIP knockdown remarkably attenuated the roles of miR-106b-5p inhibition. In conclusion, estradiol treatment on SH-SY5Y cells downregulates TXNIP expression and upregulates miR-106b-5p expression. miR-106b-5p exerts a neuroprotective effect on SH-SY5Y cells by promoting cell proliferation and inhibiting cell apoptosis through targeting TXNIP.

Topics & Concepts

TXNIPSH-SY5YThioredoxin-Interacting ProteinNeuroprotectionGene knockdownViability assayApoptosisCell biologyChemistryCellCancer researchCell cultureMolecular biologyBiologyThioredoxinBiochemistryPharmacologyOxidative stressNeuroblastomaGeneticsRedox biology and oxidative stressAlzheimer's disease research and treatmentsMicroRNA in disease regulation